\begin{table*}
    \caption{Summary of COVID-19 United States Regulatory Guidance Documents.}
    \label{tab:0801a}
    \begin{tabularx}{\textwidth}{mbs}
        \toprule
            Guidance Document & Scope & Last Update \\
        \midrule
            \href{https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised}{Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)} &
            This guidance describes a policy for laboratories and commercial manufacturers to help accelerate the use of tests they develop in order to achieve more rapid and widespread testing capacity in the US. &
            May 11, 2020 \\

            \href{https://www.fda.gov/media/138412/download}{Home Specimen Collection Molecular Diagnostic Template} &
            This template provides the FDA recommendations concerning what data and information should be submitted to FDA in support of a pre-EUA/EUA submission for prescription use only home collection devices used by an individual to collect certain clinical specimen(s) that are then sent to a clinical laboratory for testing with a molecular diagnostic for SARS-CoV-2 that is authorized for use with the home collection kit. &
            May 29, 2020 \\

            \href{https://www.fda.gov/media/135900/download}{Molecular Diagnostic Template for Commercial Manufacturers} &
            Provides FDA’s recommendations concerning what data and information should be submitted to FDA in support of a pre-EUA/EUA submission for a molecular diagnostic for SARS-CoV-2. &
            July 28, 2020 \\

            \href{https://www.fda.gov/media/135658/download}{Molecular Diagnostic Template for Laboratories} &
            Includes FDA’s recommendations for laboratories concerning what data and information they should submit to support an EUA request for a molecular diagnostic for SARS-CoV-2 developed for use in a single CLIA certified high-complexity laboratory. &
            July 28, 2020 \\

            \href{https://www.fda.gov/media/140615/download}{Template for Manufacturers of Molecular and Antigen Diagnostic COVID-19 Tests for Non-Laboratory Use} &
            Provides FDA’s recommendations concerning what data and information should be submitted to FDA in support of a pre-EUA/EUA submission for a molecular or antigen diagnostic test for SARS-CoV-2 for use in a non-laboratory setting. Such settings are likely to include a person’s home or certain non-traditional sites such as offices, sporting events, airports, schools etc. This template does not apply to home collection kits. &
            July 29, 2020 \\
        \bottomrule
    \end{tabularx}%
\end{table*}